Skip to main content
Clinical Trials/DRKS00015114
DRKS00015114
Completed
Phase 4

The effects of remifentanil on maternal hemodynamic, oxidative stress and neonatal outcome: comparison of two dosing regimens used during the induction-delivery period of caesarean section performed under general anesthesia - Maternal and fetal effects of remifentanil used during caesarean section

Clinic of Gynaecology and Obstetrics University Clinical Center Nis0 sites60 target enrollmentJuly 30, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hemodynamic and oxidative stress response to anesthesia and surgery during elective caesarean section
Sponsor
Clinic of Gynaecology and Obstetrics University Clinical Center Nis
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 30, 2018
End Date
October 7, 2018
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Clinic of Gynaecology and Obstetrics University Clinical Center Nis

Eligibility Criteria

Inclusion Criteria

  • Patients ASA I and II status, scheduled for elective caesarean section in general anesthesia who have given written informed consent.
  • All patients refuse or have absolute/relative medical contraindications to regional anesthesia.

Exclusion Criteria

  • Exclusion criteria are: known cardiac, respiratory, neurologic, renal, endocrine, psychiatric disorders, history of drug or alcohol abuse, morbid obesity, preeclampsia, predicted difficult airway management, active labor, known fetal congenital abnormalities or signs of fetal compromise.

Outcomes

Primary Outcomes

Not specified

Similar Trials